MiamiGent Member Level Wednesday, 08/07/13 12:29:35 AM
Re: Easyfoshezy post# 5172
Post #
5182
of 13717 Go
Thanks for pointing this SA article out- it was terrific!
Below is my comment to the author:
Well done, Amit!
Your article highlights how preposterous the values being attached to INO shares are at this time. Imagine, INO had a market cap of $707,995,596 yesterday and is not remotely close to having an FDA approved product to sell- if ever!
INO is currently a very heavily manipulated stock. Illiterate "newsletters", posters employing multiple aliases and a plethora of blatant twists and outright mistruths on the message boards are causing financial hurt to the gullible- from the 25% drop in 1 1/4 hours today, the 22% drop in 2 hours last week and little doubt more crashing of the stock price to come, as you forewarn.
Hopefully the naïve will be enlightened by your article and go find a reasonable stock to invest in or trade.
I had to stop trading INO because it no longer felt right. But that's just me- I wish you the best on your short.
You were much more diplomatic than me, Amit. What is going on now surrounding the INO stock is criminal and should be investigated by the Securities and Exchange Commission (SEC).
MiamiGent
In memory of Stoney
Recent example of (illiterate) pumping of INO by an internet "newsletter":
Boston, MA, 08/01/2013 (nysepost) – Recently, the stock of Inovio Pharmaceuticals Inc (NYSEMKT:INO) has found to shot up a larger 28.97% with the total number of 15.1 million shares being traded. On a technical view, the stock of Inovio Pharmaceuticals Inc has shot past the price of $ 1.50 stubborn level prior to 11.00 a.m. trading. However, the stock was found to take off during post 12.00 p.m. trading. Therefore, the stock has broken out of the increasing trend in triangle pattern. This led to the measuring implication which is the projected price of approximately $ 2.37. In this week’s trading, the shares of Inovio Pharmaceuticals Inc have also hit a new 12-month high. During the previous trading session, the stock of Inovio Pharmaceuticals Inc has earned a profit 0.69% at the price of $ 1.45 with the total numbers of 4.1 million shares being traded.
The stock of Inovio Pharmaceuticals Inc has been basking with the glow of positive results with regards to the human telomerase reverse transcriptase DNA vaccine for cancer which were administered into two of the animal models by making use of the CELLECTRA. The CELLECTRA is the adaptive technology of electroporation delivery of the vaccines. It has been announced by Inovio Pharmaceuticals Inc that the company’s hTERT DNA cancer vaccine has shown the potential for reducing the tumors and also for preventing the recurrence of tumors.
Per the reports by media, the focus of Inovio Pharmaceuticals Inc on oncology is holding the chances for making it an appropriate candidate for getting acquired by Merck. This is because Merck is suffering decline in the revenue from its oncology businesses. This has possibly helped the launch of of Inovio Pharmaceuticals Inc into one of the bullish trajectories. Inovio Pharmaceuticals Inc is a company that is re-owned for revolutionizing the vaccines that are intended for the prevention and treatment of cancers and some of the infectious diseases.
AI
